228 related articles for article (PubMed ID: 30028820)
21. HAX1 mutation positive children presenting with haemophagocytic lymphohistiocytosis.
Karapınar TH; Yılmaz Karapinar D; Oymak Y; Ay Y; Demirağ B; Aykut A; Onay H; Hazan F; Aydınok Y; Özkınay F; Vergin C
Br J Haematol; 2017 May; 177(4):597-600. PubMed ID: 28169428
[TBL] [Abstract][Full Text] [Related]
22. Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.
Wojdyla T; Mehta H; Glaubach T; Bertolusso R; Iwanaszko M; Braun R; Corey SJ; Kimmel M
PLoS Comput Biol; 2019 Jan; 15(1):e1006664. PubMed ID: 30615612
[TBL] [Abstract][Full Text] [Related]
23. Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.
Touw IP; Beekman R
Haematologica; 2013 Oct; 98(10):1490-2. PubMed ID: 24091926
[No Abstract] [Full Text] [Related]
24. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
Zeidler C; Germeshausen M; Klein C; Welte K
Br J Haematol; 2009 Feb; 144(4):459-67. PubMed ID: 19120359
[TBL] [Abstract][Full Text] [Related]
25. GM-CSF stimulates granulopoiesis in a congenital neutropenia patient with loss-of-function biallelic heterozygous CSF3R mutations.
Klimiankou M; Klimenkova O; Uenalan M; Zeidler A; Mellor-Heineke S; Kandabarau S; Skokowa J; Zeidler C; Welte K
Blood; 2015 Oct; 126(15):1865-7. PubMed ID: 26324699
[No Abstract] [Full Text] [Related]
26. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract][Full Text] [Related]
27. Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.
van de Vosse E; Verhard EM; Tool AJ; de Visser AW; Kuijpers TW; Hiemstra PS; van Dissel JT
Ann Hematol; 2011 Feb; 90(2):151-8. PubMed ID: 20803142
[TBL] [Abstract][Full Text] [Related]
28. HAX-1 deficiency: Characteristics of five cases including an asymptomatic patient.
Aydogmus C; Cipe F; Tas M; Akinel A; Öner Ö; Keskindemirci G; Bornaun H; Kutluk G; Hocaoglu AB
Asian Pac J Allergy Immunol; 2016 Mar; 34(1):73-6. PubMed ID: 26994629
[TBL] [Abstract][Full Text] [Related]
29. Inherited biallelic CSF3R mutations in severe congenital neutropenia.
Triot A; Järvinen PM; Arostegui JI; Murugan D; Kohistani N; Dapena Díaz JL; Racek T; Puchałka J; Gertz EM; Schäffer AA; Kotlarz D; Pfeifer D; Díaz de Heredia Rubio C; Ozdemir MA; Patiroglu T; Karakukcu M; Sánchez de Toledo Codina J; Yagüe J; Touw IP; Unal E; Klein C
Blood; 2014 Jun; 123(24):3811-7. PubMed ID: 24753537
[TBL] [Abstract][Full Text] [Related]
30. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.
Olofsen PA; Bosch DA; Roovers O; van Strien PMH; de Looper HWJ; Hoogenboezem RM; Barnhoorn S; Mastroberardino PG; Ghazvini M; van der Velden VHJ; Bindels EMJ; de Pater EM; Touw IP
Blood Adv; 2021 Feb; 5(3):775-786. PubMed ID: 33560392
[TBL] [Abstract][Full Text] [Related]
31. Digenic mutations in severe congenital neutropenia.
Germeshausen M; Zeidler C; Stuhrmann M; Lanciotti M; Ballmaier M; Welte K
Haematologica; 2010 Jul; 95(7):1207-10. PubMed ID: 20220065
[TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
33. [Gene Mutation and Acute Leukemia Transformation of Severe Congenital Neutropenia- Review].
Chi ZH; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1580-1584. PubMed ID: 29070147
[TBL] [Abstract][Full Text] [Related]
34. Severe congenital neutropenia in two siblings related to HAX1 mutation without neurodevelopmental disorders.
Patiroglu T; Gungor HE; Triot A; Unal E
Genet Couns; 2013; 24(3):253-8. PubMed ID: 24341138
[TBL] [Abstract][Full Text] [Related]
35. Severe congenital neutropenia.
Welte K; Zeidler C
Hematol Oncol Clin North Am; 2009 Apr; 23(2):307-20. PubMed ID: 19327585
[TBL] [Abstract][Full Text] [Related]
36. Screening of genetic variants in
Arunachalam AK; Suresh H; Edison ES; Korula A; Aboobacker FN; George B; Shaji RV; Mathews V; Balasubramanian P
J Clin Pathol; 2020 Jun; 73(6):322-327. PubMed ID: 31732620
[TBL] [Abstract][Full Text] [Related]
37. Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.
Trottier AM; Druhan LJ; Kraft IL; Lance A; Feurstein S; Helgeson M; Segal JP; Das S; Avalos BR; Godley LA
Blood Adv; 2020 Oct; 4(20):5269-5284. PubMed ID: 33108454
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.
Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC
Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295
[TBL] [Abstract][Full Text] [Related]
39. A rare case of syndromic severe congenital neutropenia: JAGN1 mutation.
Çipe FE; Aydoğmuş Ç; Baskın K; Keskindemirci G; Garncarz W; Boztuğ K
Turk J Pediatr; 2020; 62(2):326-331. PubMed ID: 32419428
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of leukemic transformation in congenital neutropenia.
Link DC
Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
